I have three boys. And I wanted to make sure it connected with them and then those guys who grew up like me, in environments like me.And then I knew something about science that your New York Times reader would be interested in. So I was thinking about it in multiple ways: I'll connect with the people who grew up like me first, and then the New York Times reader will be interested in the science because it's so good and they want to be "in the know."

I am glad that people are trying to have a rational conversation about drugs.

Writing in a nuanced way, getting at all the details in a way that remains interesting for the reader, is very difficult.

My critique of how we deal with drugs in society is just that - that we use these anecdotes to apply to everyone and the anecdotes are not representative.

When you have the national narrative being "crack is awful and black people are using it," why go against that narrative when you want to get that publication in The New York Times or wherever? It encourages people to play right into it.

High Price: A Neuroscientist's Journey of Self-Discovery That Challenges Everything You Know About Drugs and Society.

We need to continuously put pressure on politicians to do more, because they are happy just to do nothing—it’s easier to do nothing.